Orchid Cellmark selected as identity DNA testing provider by disaster management firm Kenyon International
"We believe this important contract with Kenyon International reflects Orchid Cellmark's success in applying our advanced forensic DNA techniques to help identify victims of the 9/11 World Trade Center and the Asian tsunami disasters, as well as our proven ability to consistently deliver excellent service," said Paul J. Kelly, M.D., president and chief executive officer of Orchid Cellmark. "We are pleased to have the opportunity to provide forensic DNA testing services for the world's leading disaster management company."
Most read news
Other news from the department business & finance
Get the analytics and lab tech industry in your inbox
From now on, don't miss a thing: Our newsletter for analytics and lab technology brings you up to date every Tuesday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.